Expectations from US President's State of the Union address

30 January 2006

US President George W Bush is scheduled to give his State of the Union speech on January 31, and analysts at Lehman Brothers expect this to have a major focus on covering the health costs of the uninsured Americans. They see him as majoring on expanding Health Savings Accounts, portability of health insurance and additional tax breaks for those without employer-sponsored care, as well as medical malpractice and health care information technology.

While speculation has continued that Pres Bush will propose election year health care cut, they note that Acting Majority Leader Roy Blunt, in a Wall Street Journal editorial, has called for budget reconciliation to be an annual event. The analysts believe that, if Congressman Blunt were to win majority leader, this would put momentum behind reconciliation and volatility in health services.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight